Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Deep Longevity Selected by Kickstart as One of the Most Promising Start-ups in the World Discussing Proof of Concepts with Big Insurance and Health and Wellbeing Companies 2022-08-10 22:29
Deep Longevity Published and Granted the First Microbiomic Aging Clock Patent 2022-07-07 12:18
Deep Longevity Announces Important Operational Update 2022-07-06 10:54
Endurance RP Limited (SEHK:0575.HK) Operational Update on the PE Prevention Drug Fortacin™ / Senstend™ 2022-07-05 12:06
Deep Longevity Launched a Free Self-help Application, FuturSelf, Powered by Research Conducted with Harvard Medical School, on Optimizing Future Well-being with Artificial Intelligence 2022-06-21 23:35
Endurance Longevity Signed Exclusive Licence Agreement to Commercialise Fortacin™ in the Israeli and Balkan regions 2021-12-15 15:01
Deep Longevity Launches Longevity Medicine Course for Physicians with Industry Experts 2021-10-07 15:30
Endurance RP Limited (Stock Code: 0575.HK) Announces 2021 Interim Results 2021-08-30 16:59
Endurance Longevity Announces Positive Profit Alert for Interim Results 2021 and Other Exciting Business Updates 2021-08-06 20:02
Fortacin™ Receives Extremely Encouraging Assessment in US Market Research Analysis 2021-07-28 20:05
Deep Longevity Repurposes a Blood Aging Clock for Saliva Samples 2021-07-27 21:39
Deep Longevity Releases an AI-based Predictor of COVID Time-To-Death 2021-07-26 19:08
Fortacin™ Receives Strong Positive Results for US Phase II PRO Validation Study 2021-07-15 21:27
Deep Longevity Launches Psychological Aging Clocks and Announces Scientific Advisory Board 2021-07-14 22:35
Deep Longevity Releases a CME-accredited Course on Longevity Medicine 2021-07-13 20:21
Endurance RP Limited: A New Name, A New Perspective Eye on China's fertility and longevity market 2021-06-23 22:33
Regent Pacific's Deep Longevity Announces Partnership with LifeHub & LifeClinic in Hong Kong 2021-05-20 12:00
Regent Pacific's Unrealised Gain in Venturex Resources Limited Increased to US$10.74 million 2021-05-12 15:04
Regent Pacific Receives HK$24.96 million After Clinical Trial Approval For FORTACIN(TM) Has Been Obtained 2021-04-01 21:11
Deep Longevity Publishes Article About Preventing COVID-19 and Aging 2021-02-16 17:20
1 2